Main Menu
Login
Related Links
More news sources
News Submission
Special News Items
- FDA Lifts Clinical Hold; Green-Lights Vertex and CRISPR’s Sickle Cell Gene Therapy Trial
- Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository Experience
- European Commission Approves Novartis’ Kymriah CAR-T Cell Therapy
- Health Officials Remove Special NIH Oversite Rules Governing Gene Therapy Experiments
- FDA Seeks to Enhance Manufacturing of Cell and Gene Therapies
- New EU initiatives to optimize the interplay between the Pharma and the GMO framework
- Caution required for using CRISPR/Cas9 in potential gene therapies
- First cohort enrolled in trial with innovative gene therapy for arthritis
- FDA Aims to Facilitate Gene Therapy Development for Hemophilia, Rare Diseases
- New UK consortium looks to make breakthrough in gene therapy manufacture
- Gene-Therapy Company Crispr Drops as FDA Puts Trial on Hold
- A Harvard startup is using gene therapy to reverse ageing in dogs, humans are next
- Latest Up and Coming Gene Therapies
- Gene therapy for beta-thalassemia safe, effective in people
- 13-Year-Old Boy Is First Person in US to Receive Newly Approved Gene Therapy for Blindness
- Gene therapy found safe in trial of Pompe disease treatment
- High-dose AAV gene therapy appears toxic in monkeys and piglets
- Chinese scientists used Crispr gene editing on 86 human patients
- Gene Therapy For Rare Forms Of Blindness Will Cost Nearly Half A Million Per Eye
- Gene therapy shows 'mind-blowing' success in treating haemophilia A